Radionetics Oncology
Jillian Basinger Thompson is a seasoned Patent Agent with extensive experience in the chemical and biotechnology sectors, currently serving at Radionetics Oncology since August 2022. Prior roles include Patent Agent II at Foley & Lardner LLP and Patent Agent at Mintz, where responsibilities encompassed drafting and prosecuting patent applications. Jillian's background includes significant experience as an Associate Scientist at Dart NeuroScience LLC, focusing on chemical intellectual property and medicinal chemistry, having synthesized and analyzed small molecules in pharmaceutical contexts. Additional noteworthy positions include contract editing for AJE - American Journal Experts and an Assistant Scientist role at Ligand Pharmaceuticals. Educational qualifications include an MS in Chemistry from UC San Diego and a BS in Chemistry from San Jose State University.
This person is not in any teams
Radionetics Oncology
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company’s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.